申请人:Merrell Dow Pharmaceuticals Inc.
公开号:US05039695A1
公开(公告)日:1991-08-13
This invention relates to the method of using aryl- or heteroaryl-1-alkyl-pyrrole-2-carboxylic acid compounds to treat interleukin-1 mediated conditions.
这项发明涉及使用芳基或杂环芳基-1-烷基-吡咯烷-2-羧酸化合物治疗白细胞介素-1介导的疾病。